UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$469M |
| 2 |
Fidelity National Information Services
FIS
|
+$352M |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$337M |
| 4 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$316M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$292M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.92B |
| 2 |
UBS Group
UBS
|
+$1.46B |
| 3 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$547M |
| 4 |
Microsoft
MSFT
|
+$461M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.47% |
| 2 | Financials | 6.72% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 5.76% |
| 5 | Industrials | 5.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Allegiant Air
ALGT
$2.57B
| $1.9M | ﹤0.01% |
12,682
-1,181
| -9% | -$173K |
|
3327
CALL
Lam Research
LRCX
$390B
| $1.9M | ﹤0.01% |
+82,000
| New | +$1.72M |
|
|
3328
PUT
Lam Research
LRCX
$390B
| $1.9M | ﹤0.01% |
+82,000
| New | +$1.72M |
|
3329
CALL
Bloomin' Brands
BLMN
$938M
| $1.89M | ﹤0.01% |
100,000
| – | – |
|
3330
Travere Therapeutics
TVTX
$5.78B
| $1.89M | ﹤0.01% |
163,180
+140,411
| +617% | +$2.32M |
|
3331
CALL
Sibanye-Stillwater
SBSW
$7.53B
| $1.89M | ﹤0.01% |
350,000
-350,000
| -50% | -$1.78M |
|
3332
RB Global
RBA
$17.5B
| $1.89M | ﹤0.01% |
47,309
-4,028
| -8% | -$150K |
|
3333
Beazer Homes USA
BZH
$907M
| $1.89M | ﹤0.01% |
126,667
+67,852
| +115% | +$817K |
|
|
EHI
3334
Western Asset Global High Income Fund
EHI
$178M
| $1.89M | ﹤0.01% |
189,888
+7,920
| +4% | +$78.1K |
|
3335
Elastic
ESTC
$7.81B
| $1.88M | ﹤0.01% |
22,867
+16,242
| +245% | +$1.44M |
|
|
VTLE
3336
DELISTED
Vital Energy
VTLE
| $1.88M | ﹤0.01% |
38,912
+3,580
| +10% | +$198K |
|
3337
Principal Spectrum Preferred Securities Active ETF
PREF
$1.78B
| $1.87M | ﹤0.01% |
94,070
+10,385
| +12% | +$204K |
|
3338
The RealReal
REAL
$1.5B
| $1.87M | ﹤0.01% |
83,767
+83,035
| +11,344% | +$1.67M |
|
3339
Insight Enterprises
NSIT
$4.38B
| $1.87M | ﹤0.01% |
33,551
+15,878
| +90% | +$839K |
|
3340
Banner Corp
BANR
$2.4B
| $1.87M | ﹤0.01% |
31,544
-118,194
| -79% | -$6.52M |
|
3341
CRISPR Therapeutics
CRSP
$5.17B
| $1.86M | ﹤0.01% |
45,457
-11,507
| -20% | -$550K |
|
|
OSG
3342
Octave Specialty Group
OSG
$222M
| $1.86M | ﹤0.01% |
95,223
+28,287
| +42% | +$520K |
|
3343
ALPS Disruptive Technologies ETF
DTEC
$75.7M
| $1.86M | ﹤0.01% |
64,039
-35,666
| -36% | -$1.06M |
|
3344
ICU Medical
ICUI
$4.61B
| $1.86M | ﹤0.01% |
11,657
-1,882
| -14% | -$375K |
|
|
GARS
3345
DELISTED
Garrison Capital Inc.
GARS
| $1.86M | ﹤0.01% |
269,034
-10,336
| -4% | -$72.3K |
|
3346
Worthington Enterprises
WOR
$2.86B
| $1.86M | ﹤0.01% |
83,505
-316,884
| -79% | -$7.34M |
|
|
THW
3347
abrdn World Healthcare Fund
THW
$551M
| $1.85M | ﹤0.01% |
138,024
+8,898
| +7% | +$118K |
|
3348
CALL
iShares MSCI Mexico ETF
EWW
$1.99B
| $1.85M | ﹤0.01% |
43,400
-56,600
| -57% | -$2.36M |
|
3349
US Physical Therapy
USPH
$1.22B
| $1.85M | ﹤0.01% |
14,205
+9,662
| +213% | +$1.26M |
|
3350
Primerica
PRI
$9.89B
| $1.85M | ﹤0.01% |
14,553
-5,636
| -28% | -$680K |
|
Similar funds
UBS Group's Q3 2019 Portfolio in Review
As of Q3 2019, UBS Group held 8,655 positions worth $260B, up 0.05% from $260B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q3 2019 filing shows 737 new, 4,060 increased, 2,893 reduced and 594 closed positions. Its largest new stake was Invesco S&P Ultra Dividend Revenue ETF: 1,020,769 shares worth $38.5M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 9.5% of assets, down from 9.7% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q3 2019 buy was Invesco S&P Ultra Dividend Revenue ETF: 1,020,769 shares worth $38.5M.
- UBS Group added most to iShares US Treasury Bond ETF in Q3 2019, an estimated $469M increase.
- UBS Group's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.92B.
- UBS Group fully exited OAKTREE CAPITAL GROUP, LLC in Q3 2019, selling an estimated $172M.
- UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q3 2019.
- UBS Group opened 737 new positions and closed 594 in Q3 2019.
- UBS Group's portfolio value rose 0.05% quarter-over-quarter to $260B.
Based on UBS Group's 13F filing for Q3 2019, filed 14 Nov 2019.